On Wednesday afternoon, hearing aid manufacturers GN and Demant's share prices dropped on OMX Copenhagen 25, after rumors began to spread that Apple is investigating whether its Airpods product can be used as a solution for hearing health. The rumors were reported by the Wall Street Journal, referring to sources it says are familiar with Apple's plans.
It is not readily apparent if Apple wants to develop new, specific hearing device functions for the Airpods, or if the tech giant is seeking to brand the earbuds' existing hearing enchancing features as hearing aid functions.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Carb-X secures USD 370m in fight against antibiotic resistance
International antibiotic alliance Carb-X has received commitments of up to USD 370m to accelerate the development of new antibiotics to combat a future shortage. The news is welcomed by several players on the AMR field.
Former Ambu CEO's equity investments end in USD 2m losses
Juan Jose Gonzalez, who was the CEO of medtech firm Ambu until very recently, has lost just over DKK 16m (USD 2.3m) before taxes on his share purchases.
Jesper Høiland retires as chief commercial officer of Ascendis Pharma
Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.
ALK finds replacement for long-time North America lead
Jorge Alderete, ALK’s president in North America, is leaving the firm after 23 years. He will be replaced by Hans Lindeberg, ALK’s current head of the Nordic region.
Monkeypox vaccine attracts interest for Bavarian as virus spreads
Bavarian, which signed a supply contract with an unnamed European country last week, reports it is in dialog with several countries, some yet to be affected, concerning the firm’s monkeypox vaccine.
Clinical Project Manager 
Account Manager 
Laboratory technician for process development and clinical manufacturing 
Director Global Engineering 
Key Account Manager, Europe and Asia 
Client Talent Acquisition Specialist 
Senior Chemical Safety Advisor 
IRT Manager, Clinical Drug Supply 
Director of Toxicology 
Director for innovative pre-clinical testing unit 
Industrial Designer- Design Engineer 
Nordic Medical Affairs Manager 
Project Manager & Scrum Master 
(Senior) Drug Substance Specialist 
System Sales Development Consultant - Investment Projects, Merck Millipore 
2 Sales Representatives and Product Specialists 
Biomarker Operations Lead